CompletedPhase 3NCT00162032
A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease
Studying Kawasaki disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Lantheus Medical Imaging
- Principal Investigator
- Qi Zhu, MD,Lantheus Medical Imaging
- Intervention
- Sestamibi(drug)
- Enrollment
- 445 enrolled
- Eligibility
- 4-16 years · All sexes
- Timeline
- 2005 – 2010
Study locations (30)
- Local Institution, Anchorage, Alaska, United States
- Local Institution, Little Rock, Arkansas, United States
- Local Institution, Los Angeles, California, United States
- Local Institution, Orange, California, United States
- Local Institution, San Diego, California, United States
- Local Institution, Denver, Colorado, United States
- Local Institution, Hartford, Connecticut, United States
- Local Institution, New Haven, Connecticut, United States
- Local Institution, Honolulu, Hawaii, United States
- Local Institution, Chicago, Illinois, United States
- Local Institution, Park Ridge, Illinois, United States
- Local Institution, Indianapolis, Indiana, United States
- Local Institution, Lexington, Kentucky, United States
- Local Institution, Boston, Massachusetts, United States
- Local Institution, Las Vegas, Nevada, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00162032 on ClinicalTrials.govOther trials for Kawasaki disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT05643651Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki DiseaseChildren's Hospital of Fudan University
- RECRUITINGNANCT07291245Kawasaki MATCH TrialUniversity of California, San Diego
- ENROLLING BY INVITATIONNCT06641843Magnetic Resonance Myocardial Stress Perfusion in Pediatric Patients with Cardiovascular DiseaseWest China Second University Hospital
- RECRUITINGPHASE4NCT06978439Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki DiseaseChildren's Hospital of Fudan University
- RECRUITINGPHASE3NCT04656184A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG TreatmentAssistance Publique - Hôpitaux de Paris
- ENROLLING BY INVITATIONNCT06641817The Value of Cardiovascular Imaging in Kawasaki DiseaseWest China Second University Hospital
- RECRUITINGNCT06993636Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 YearsChildren's Hospital of Fudan University
- RECRUITINGNCT06305611European and North Indian Cohort of KaWasaki dIseaseMeyer Children's Hospital IRCCS